ReviewCurrent osteoporosis reports2026
Microgravity-Induced Osteocyte Dysfunction: An Osteocyte Mechanobiology Unit Framework.
Review in Current osteoporosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review synthesizes evidence from diverse experimental platforms and proposes the Osteocyte Mechanobiology Unit (OMU), a conceptual framework integrating the mechanical and biochemical processes underlying microgravity-induced alterations in osteocytes and their surrounding microenvironment. RECENT
findingsCurrent evidence indicates that microgravity disrupts two interconnected OMU domains: the Mechanical Sensing Domain, through alterations in the local mechanical microenvironment and mechanosensory structures, and the Biochemical Signaling Domain, through dysregulated cellular homeostasis, altered osteocyte functional phenotype, and disrupted intercellular and systemic signaling. This synthesis highlights important knowledge gaps, including the fragmented nature of current evidence, the limited understanding of the relationships among these alterations and their contribution to bone loss, and the need for validation under actual spaceflight conditions. The OMU framework provides a unifying physiological perspective for interpreting fragmented evidence and organizing countermeasures against microgravity-induced bone loss according to the functional domains they target. It also identifies priorities for developing integrated, mechanism-informed strategies to preserve skeletal health during long-duration human spaceflight.
Indexed as
Identifiers
42827190What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.